|
Atrion Corporation (NASDAQ: ATRI) |
|
Atrion Corporation
ATRI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Atrion growth rates, revenue grew
by 21.95 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 631
Medical Equipment & Supplies industry recorded
growth of revenues by 2.42 %
Atrion's net profit decreased by -88.46 % in II. Quarter 2024 year on year, to $0 millions.
• More on ATRI's Growth
|
|
Atrion current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.
Company is currently trading with Price to Cash flow multiple of 203.12 in trailing twelve-month period. |
Company |
63.7 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.12.
• More on ATRI's Valuation
|
|
|
|
|
Atrion current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.
Company is currently trading with Price to Cash flow multiple of 203.12 in trailing twelve-month period. |
Company |
63.7 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 4.46.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.12.
Atrion Price to Book Ratio is at 3.39 higher than Industry Avg. of -460.18, and higher than S&P 500 Avg. of 0.01
• More on ATRI's Valuation
|
|
ATRI's Profitability Comparisons
|
Atrion faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 1.09 % from 6.64 % in I. Quarter.
Atrion net profit margin of 0.82 % is currently ranking no. 60 in Medical Equipment & Supplies industry, ranking no. 186 in Healthcare sector and number 2352 in S&P 500.
Profitability by Segment |
Total |
0.82 % |
|
|
Atrion faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 1.09 % from 6.64 % in I. Quarter.
Atrion net profit margin of 0.82 % is currently ranking no. 60 in Medical Equipment & Supplies industry, ranking no. 186 in Healthcare sector and number 2352 in S&P 500.
• More on ATRI's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com